Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Active-controlled, Non-inferiority, Multicenter Phase III Study to Evaluate the Efficacy and Safety of HCP1004 as Compared to RLD2401 in Chronic Low-Back Pain Patients
Conditions
Interventions
HCP1004
RLD2401
Locations
1
South Korea
Hanyang University Seoul Hospital
Seoul, Seoul, South Korea
Start Date
November 22, 2024
Primary Completion Date
June 18, 2025
Completion Date
June 18, 2025
Last Updated
December 15, 2025
NCT06169488
NCT05508360
NCT04658628
NCT05780021
NCT06080464
NCT06831994
Lead Sponsor
Hanmi Pharmaceutical Company Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions